BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21084310)

  • 1. Characterization of a binding site for anionic phospholipids on KCNQ1.
    Thomas AM; Harmer SC; Khambra T; Tinker A
    J Biol Chem; 2011 Jan; 286(3):2088-100. PubMed ID: 21084310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I(KS) regulation by PKA and PIP₂.
    Dvir M; Strulovich R; Sachyani D; Ben-Tal Cohen I; Haitin Y; Dessauer C; Pongs O; Kass R; Hirsch JA; Attali B
    J Cell Sci; 2014 Sep; 127(Pt 18):3943-55. PubMed ID: 25037568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease pathogenesis in long QT syndrome type 5.
    Harmer SC; Wilson AJ; Aldridge R; Tinker A
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C263-73. PubMed ID: 19907016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The
    Wang Y; Eldstrom J; Fedida D
    Mol Pharmacol; 2020 Feb; 97(2):132-144. PubMed ID: 31722973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNQ1 channels do not undergo concerted but sequential gating transitions in both the absence and the presence of KCNE1 protein.
    Meisel E; Dvir M; Haitin Y; Giladi M; Peretz A; Attali B
    J Biol Chem; 2012 Oct; 287(41):34212-24. PubMed ID: 22908235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activation.
    Kuenze G; Vanoye CG; Desai RR; Adusumilli S; Brewer KR; Woods H; McDonald EF; Sanders CR; George AL; Meiler J
    Elife; 2020 Oct; 9():. PubMed ID: 33095155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol-4,5-bisphosphate is required for KCNQ1/KCNE1 channel function but not anterograde trafficking.
    Royal AA; Tinker A; Harmer SC
    PLoS One; 2017; 12(10):e0186293. PubMed ID: 29020060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
    Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
    Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels.
    Yu H; Lin Z; Mattmann ME; Zou B; Terrenoire C; Zhang H; Wu M; McManus OB; Kass RS; Lindsley CW; Hopkins CR; Li M
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8732-7. PubMed ID: 23650380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.
    Li Y; Chen L; Kass RS; Dessauer CW
    J Biol Chem; 2012 Aug; 287(35):29815-24. PubMed ID: 22778270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a protein-protein interaction between KCNE1 and the activation gate machinery of KCNQ1.
    Lvov A; Gage SD; Berrios VM; Kobertz WR
    J Gen Physiol; 2010 Jun; 135(6):607-18. PubMed ID: 20479109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNE variants reveal a critical role of the beta subunit carboxyl terminus in PKA-dependent regulation of the IKs potassium channel.
    Kurokawa J; Bankston JR; Kaihara A; Chen L; Furukawa T; Kass RS
    Channels (Austin); 2009; 3(1):16-24. PubMed ID: 19077539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1.
    Chan PJ; Osteen JD; Xiong D; Bohnen MS; Doshi D; Sampson KJ; Marx SO; Karlin A; Kass RS
    J Gen Physiol; 2012 Feb; 139(2):135-44. PubMed ID: 22250012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic modulation of KCNQ1/KCNE1 K(+) channels (IKs) by phosphatidylinositol 4,5-bisphosphate (PIP2) and [ATP]i.
    Kienitz MC; Vladimirova D
    Cell Signal; 2015 Jul; 27(7):1457-68. PubMed ID: 25892084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.
    Nakajo K; Ulbrich MH; Kubo Y; Isacoff EY
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18862-7. PubMed ID: 20962273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel.
    Chen J; Zheng R; Melman YF; McDonald TV
    PLoS One; 2009; 4(4):e5143. PubMed ID: 19340287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
    Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
    Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of S4 charges in voltage-dependent and voltage-independent KCNQ1 potassium channel complexes.
    Panaghie G; Abbott GW
    J Gen Physiol; 2007 Feb; 129(2):121-33. PubMed ID: 17227916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels.
    Loussouarn G; Park KH; Bellocq C; Baró I; Charpentier F; Escande D
    EMBO J; 2003 Oct; 22(20):5412-21. PubMed ID: 14532114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.